ABCM Stock Price, Chart, Stats & News

Abcam plc
Save
5.52B
Market cap
2399.00x
Current P/E
–
Forward P/E
ABCM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 74.79% |
Operating margin | -2.82% |
Pretax margin | -4.31% |
Net margin | -2.35% |
Effective tax rate | 45.51% |
ROA | -0.80% |
ROE | -1.23% |
D/E | 0.31x |
Interest coverage ratio | -1.89x |
ABCM valuation
P/E | 2399.00x |
P/S | 11.51x |
P/B | 5.69x |
P/CF | 144.16x |
P/FCF | -330.44x |
P/OCF | 144.16x |
PEG | -6.45x |
EV multiple | 94.35x |
About
Abcam plc operates as a prominent life science enterprise, dedicated to the innovation, creation, and supply of crucial reagents and instruments. These fundamental resources are instrumental in supporting diverse scientific investigations, diagnostic applications, and the advancement of pharmaceutical drug discovery initiatives. Its comprehensive product portfolio features primary and secondary antibodies, conjugated antibodies paired with their respective kits, both singleplex and multiplex immunoassays, as well as a variety of proteins and peptides, including cytokines.
Similar securities
Based on sector and market capitalization
Report issue











